142 related articles for article (PubMed ID: 24882746)
1. Structural and mechanistic paradigm of leptin receptor activation revealed by complexes with wild-type and antagonist leptins.
Moharana K; Zabeau L; Peelman F; Ringler P; Stahlberg H; Tavernier J; Savvides SN
Structure; 2014 Jun; 22(6):866-77. PubMed ID: 24882746
[TBL] [Abstract][Full Text] [Related]
2. 20 years of leptin: insights into signaling assemblies of the leptin receptor.
Peelman F; Zabeau L; Moharana K; Savvides SN; Tavernier J
J Endocrinol; 2014 Oct; 223(1):T9-23. PubMed ID: 25063754
[TBL] [Abstract][Full Text] [Related]
3. Mapping of binding site III in the leptin receptor and modeling of a hexameric leptin.leptin receptor complex.
Peelman F; Iserentant H; De Smet AS; Vandekerckhove J; Zabeau L; Tavernier J
J Biol Chem; 2006 Jun; 281(22):15496-504. PubMed ID: 16540470
[TBL] [Abstract][Full Text] [Related]
4. Ligand-induced architecture of the leptin receptor signaling complex.
Mancour LV; Daghestani HN; Dutta S; Westfield GH; Schilling J; Oleskie AN; Herbstman JF; Chou SZ; Skiniotis G
Mol Cell; 2012 Nov; 48(4):655-61. PubMed ID: 23063524
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of naturally occurring pathogenic mutations in the human leptin receptor.
Kimber W; Peelman F; Prieur X; Wangensteen T; O'Rahilly S; Tavernier J; Farooqi IS
Endocrinology; 2008 Dec; 149(12):6043-52. PubMed ID: 18703626
[TBL] [Abstract][Full Text] [Related]
6. Leptin receptor activation depends on critical cysteine residues in its fibronectin type III subdomains.
Zabeau L; Defeau D; Iserentant H; Vandekerckhove J; Peelman F; Tavernier J
J Biol Chem; 2005 Jun; 280(24):22632-40. PubMed ID: 15840566
[TBL] [Abstract][Full Text] [Related]
7. Atomistic mechanism of leptin and leptin-receptor association.
López-Hidalgo M; Caro-Gómez LA; Romo-Rodríguez R; Herrera-Zuñiga LD; Anaya-Reyes M; Rosas-Trigueros JL; Benítez-Cardoza CG
J Biomol Struct Dyn; 2023 Apr; 41(6):2231-2248. PubMed ID: 35075977
[TBL] [Abstract][Full Text] [Related]
8. A novel leptin receptor antagonist uncouples leptin's metabolic and immune functions.
Zabeau L; Wauman J; Dam J; Van Lint S; Burg E; De Geest J; Rogge E; Silva A; Jockers R; Tavernier J
Cell Mol Life Sci; 2019 Mar; 76(6):1201-1214. PubMed ID: 30659329
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of high affinity leptins and leptin antagonists.
Shpilman M; Niv-Spector L; Katz M; Varol C; Solomon G; Ayalon-Soffer M; Boder E; Halpern Z; Elinav E; Gertler A
J Biol Chem; 2011 Feb; 286(6):4429-42. PubMed ID: 21119198
[TBL] [Abstract][Full Text] [Related]
10. Pierced Lasso Bundles are a new class of knot-like motifs.
Haglund E; Sulkowska JI; Noel JK; Lammert H; Onuchic JN; Jennings PA
PLoS Comput Biol; 2014 Jun; 10(6):e1003613. PubMed ID: 24945798
[TBL] [Abstract][Full Text] [Related]
11. Structure of the human obesity receptor leptin-binding domain reveals the mechanism of leptin antagonism by a monoclonal antibody.
Carpenter B; Hemsworth GR; Wu Z; Maamra M; Strasburger CJ; Ross RJ; Artymiuk PJ
Structure; 2012 Mar; 20(3):487-97. PubMed ID: 22405007
[TBL] [Abstract][Full Text] [Related]
12. Large-scale preparation and characterization of non-pegylated and pegylated superactive ovine leptin antagonist.
Niv-Spector L; Shpilman M; Boisclair Y; Gertler A
Protein Expr Purif; 2012 Feb; 81(2):186-92. PubMed ID: 22040607
[TBL] [Abstract][Full Text] [Related]
13. Mapping of the leptin binding sites and design of a leptin antagonist.
Peelman F; Van Beneden K; Zabeau L; Iserentant H; Ulrichts P; Defeau D; Verhee A; Catteeuw D; Elewaut D; Tavernier J
J Biol Chem; 2004 Sep; 279(39):41038-46. PubMed ID: 15213225
[TBL] [Abstract][Full Text] [Related]
14. Leptin: From structural insights to the design of antagonists.
Zabeau L; Peelman F; Tavernier J
Life Sci; 2015 Nov; 140():49-56. PubMed ID: 25998027
[TBL] [Abstract][Full Text] [Related]
15. The Use of Small-Angle Scattering for the Characterization of Multi Subunit Complexes.
Round A
Adv Exp Med Biol; 2016; 896():329-50. PubMed ID: 27165335
[TBL] [Abstract][Full Text] [Related]
16. Structural insights into the interaction of IL-33 with its receptors.
Liu X; Hammel M; He Y; Tainer JA; Jeng US; Zhang L; Wang S; Wang X
Proc Natl Acad Sci U S A; 2013 Sep; 110(37):14918-23. PubMed ID: 23980170
[TBL] [Abstract][Full Text] [Related]
17. Structural Reconstruction of Protein-Protein Complexes Involved in Intracellular Signaling.
Kirsch K; Sok P; Reményi A
Adv Exp Med Biol; 2016; 896():315-26. PubMed ID: 27165334
[TBL] [Abstract][Full Text] [Related]
18. Identification of the hydrophobic strand in the A-B loop of leptin as major binding site III: implications for large-scale preparation of potent recombinant human and ovine leptin antagonists.
Niv-Spector L; Gonen-Berger D; Gourdou I; Biener E; Gussakovsky EE; Benomar Y; Ramanujan KV; Taouis M; Herman B; Callebaut I; Djiane J; Gertler A
Biochem J; 2005 Oct; 391(Pt 2):221-30. PubMed ID: 15952938
[TBL] [Abstract][Full Text] [Related]
19. Application of Nuclear Magnetic Resonance and Hybrid Methods to Structure Determination of Complex Systems.
Prischi F; Pastore A
Adv Exp Med Biol; 2016; 896():351-68. PubMed ID: 27165336
[TBL] [Abstract][Full Text] [Related]
20. Leptin's metabolic and immune functions can be uncoupled at the ligand/receptor interaction level.
Zabeau L; Jensen CJ; Seeuws S; Venken K; Verhee A; Catteeuw D; van Loo G; Chen H; Walder K; Hollis J; Foote S; Morris MJ; Van der Heyden J; Peelman F; Oldfield BJ; Rubio JP; Elewaut D; Tavernier J
Cell Mol Life Sci; 2015 Feb; 72(3):629-644. PubMed ID: 25098352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
